Voyager Therapeutics GAAP EPS of -$0.47 beats by $0.05, revenue of $13.37M beats by $5.51M
Source: SeekingAlpha
2025-11-10 08:15:00 ET
More on Voyager Therapeutics
- Voyager Therapeutics, Inc. (VYGR) Presents at Citi's Biopharma Back to School Conference - Slideshow
- Voyager Therapeutics, Inc. (VYGR) Presents At Citi's Biopharma Back To School Conference Transcript
- Seeking Alpha’s Quant Rating on Voyager Therapeutics
- Historical earnings data for Voyager Therapeutics
- Financial information for Voyager Therapeutics
Read the full article on Seeking Alpha
For further details see:
Voyager Therapeutics GAAP EPS of -$0.47 beats by $0.05, revenue of $13.37M beats by $5.51M
Voyager Therapeutics Inc.
NASDAQ: VYGR
VYGR Trading
0.61% G/L:
$4.93 Last:
390,106 Volume:
$5.15 Open:
VYGR Latest News
March 09, 2026 04:01:00 pm
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
VYGR Stock Data
$301,853,951
50,692,821
0.13%
37
N/A
Biotechnology & Life Sciences
Healthcare
US
Lexington
